Drug adverse event reports (FAERS) 1
- Paralysis, Peripheral coldness
Drugs: PREDNISONE., TOPIRAMATE., DAIVOBET +2
Every openFDA database, in one search.
30 datasets, 55,850,846 records: approvals, labels, NDCs, shortages, recalls, adverse event reports, device clearances and UDIs, substances, complete response letters and more. openFDA exported the newest on 2026-10-05.
Read today's FDA daily →State and federal rules by category →
“hyaluronic acid filler” matches in 7 of 26 searchable datasets. 19 did not answer this time (Approvals (Drugs@FDA), Orange Book, Drug labels, NDC directory, Drug shortages, Drug recalls, Device classification, 510(k) clearances, PMA approvals, Establishments and listings, COVID-19 serology test evaluations, Food recalls, Food and supplement adverse event reports (CAERS), Animal drug adverse event reports, Tobacco product problem reports, UNII codes, NDC SPL data elements, Historical FDA documents, Complete response letters); try again shortly.
Drugs
Devices
Device recalls 1
- Enhancement Medical expression. model # EXP-150. Injectable Gel 1.5cc Syringe with hyaluronic acid concentration of 20 mg/ml. Product Usage…FDA page
Enhancement Medical, LLC · Manufacturer made a change in the production process that resulted in a change in final gel weight. RECALL EXPANDED 7/8/2014 Firm expanded their recall to incl…
Device recall enforcement reports 1
- Enhancement Medical expression. model # EXP-150. Injectable Gel 1.5cc Syringe with hyaluronic acid concentration of 20 mg/ml. Product Usage…
Enhancement Medical, LLC · Manufacturer made a change in the production process that resulted in a change in final gel weight. RECALL EXPANDED 7/8/2014 Firm expanded their recall to incl…
Unique device identifiers (GUDID) 1
- Belotero Balance · 8700M0FDA page
MERZ NORTH AMERICA, INC. · Belotero Balance is a hyaluronic-acid based dermal filler approved for injection into the mid-to-deep dermis for correc…
Device adverse event reports (MAUDE) 411
- RHA 3 Mepi · Hyaluronic Acid Dermal Filler Gel
Teoxane SA · Improper or Incorrect Procedure or Method
- RHA 4 · Hyaluronic Acid Dermal Filler Gel
Teoxane SA · Off-Label Use, Improper or Incorrect Procedure or Method
- RHA 2 · Hyaluronic Acid Dermal Filler Gel
Teoxane SA · Improper or Incorrect Procedure or Method, Adverse Event Without Identified Device or Use Problem
Cosmetics
Cosmetic adverse event reports 1
- L'Oreal Paris Oap Revitalift Filler Hyaluronic Acid Eye Serum, Neutrogena Sunscreen Spf 100
Reactions: Application Site Pain, Erythema, Eye Swelling +2
Substances & reference
Substances (GSRS) 8
- D.S.H. CNFDA page
Also: DIMETHYLSILANOL HYALURONATE, DIMETHYLSILYL HYALURONATE, HYALURONIC ACID, DIMETHYLSILYL ESTER
- HYALURONIC ACID, 4-((1R,2S)-2-(BENZOYLAMINO)-1-((((2AR,4S,4AS,6R,9S,11S,12S,12AR,12BS)-6,12B-BIS(AC…FDA page
Also: PACLITAXEL OBALURONATE, paclitaxel obaluronate [INN]
- HYALURONIC ACID BUTYRATE FORMATE SODIUM SALTFDA page
Also: HYALURONIC ACID, BUTANOATE (ESTER) FORMATE (ESTER), SODIUM SALT, POLYHABF, SODIUM BUTYROYL/FORMOYL HYALURONATE
From FDA's records to your order.
Join free with your NPI to buy from vendors whose licenses MedGrid has reviewed, at wholesale pricing.
Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.